Enovix Corp Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Enovix Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q3 2024.
  • Enovix Corp Nonoperating Income (Expense) for the quarter ending September 29, 2024 was $28.8M, a 15.7% decline year-over-year.
  • Enovix Corp Nonoperating Income (Expense) for the twelve months ending September 29, 2024 was $24.6M, a 45.7% decline year-over-year.
  • Enovix Corp annual Nonoperating Income (Expense) for 2023 was $15.5M, a 80.7% decline from 2022.
  • Enovix Corp annual Nonoperating Income (Expense) for 2022 was $80.4M.
  • Enovix Corp annual Nonoperating Income (Expense) for 2021 was -$56.4M, a 250% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $24.6M $28.8M -$5.38M -15.7% Jul 1, 2024 Sep 29, 2024 10-Q 2024-10-30
Q2 2024 $30M -$31.8M -$19.3M -155% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $49.3M $23.5M +$33.8M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $15.5M $4.11M -$29.9M -87.9% Oct 2, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $45.4M $34.2M +$82.5M Jul 3, 2023 Oct 1, 2023 10-Q 2024-10-30
Q2 2023 -$37.2M -$12.5M -$39.4M -146% Apr 3, 2023 Jul 2, 2023 10-Q 2024-08-05
Q1 2023 $2.18M -$10.4M -$78.2M -115% Jan 2, 2023 Apr 2, 2023 10-Q 2024-05-07
Q4 2022 $80.4M $34M +$93.8M Oct 3, 2022 Jan 1, 2023 10-K 2024-02-29
Q3 2022 -$13.4M -$48.3M -$56.7M -678% Jul 4, 2022 Oct 2, 2022 10-Q 2023-11-09
Q2 2022 $43.3M $26.9M +$27M Apr 4, 2022 Jul 3, 2022 10-Q 2023-08-09
Q1 2022 $16.3M $67.8M +$72.6M Jan 3, 2022 Apr 3, 2022 10-Q 2023-05-05
Q4 2021 -$56.4M -$59.8M Oct 4, 2021 Jan 2, 2022 10-K 2024-02-29
Q3 2021 $8.36M +$15.4M Jul 1, 2021 Oct 3, 2021 10-Q 2022-11-04
Q2 2021 -$120K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$4.78M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-18
Q3 2020 -$7.03M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.